FDA panel greenlights Boehringer's stroke prevention drug Pradaxa - Cardiovascular Business PDF Print
Cardiovascular BusinessThe FDA's Cardiovascular and Renal Drug advisory committee has has unanimously voted, nine to zero, in favor of Boehringer Ingelheim Pharmaceuticals'

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.